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objective. To describe an outbreak of invasive methicillin-resistant Staphylococcus aureus (MRSA) infection after percutaneous needle
procedures (acupuncture and joint injection) performed by a single medical practitioner.
setting. A medical practitioner’s office and 4 hospitals in Perth, Western Australia.
patients. Eight individuals who developed invasive MRSA infection after acupuncture or joint injection performed by the medical prac-
titioner.
methods. We performed a prospective and retrospective outbreak investigation, including MRSA colonization surveillance, environmental
sampling for MRSA, and detailed molecular typing of MRSA isolates. We performed an infection control audit of the medical practitioner’s
premises and practices and administered MRSA decolonization therapy to the medical practitioner.
results. Eight cases of invasive MRSA infection were identified. Seven cases occurred as a cluster in May 2004; another case (identified
retrospectively) occurred approximately 15 months earlier in February 2003. The primary sites of infection were the neck, shoulder, lower back,
and hip: 5 patients had septic arthritis and bursitis, and 3 had pyomyositis; 3 patients had bacteremia, including 1 patient with possible
endocarditis. The medical practitioner was found to be colonized with the same MRSA clone [ST22-MRSA-IV (EMRSA-15)] at 2 time points:
shortly after the first case of infection in March 2003 and again in May 2004. After the medical practitioner’s premises and practices were audited
and he himself received MRSA decolonization therapy, no further cases were identified.
conclusions. This outbreak most likely resulted from a breakdown in sterile technique during percutaneous needle procedures, resulting
in the transmission of MRSA from the medical practitioner to the patients. This report demonstrates the importance of surveillance and
molecular typing in the identification and control of outbreaks of MRSA infection.





uly 2Staphylococcus aureus is highly successful at causing serious
infection in humans. This versatile organism is also well recog-
nized for its ability to be transmitted from person to person by
direct or indirect contact. Methicillin-resistant S. aureus
(MRSA) is endemic in many healthcare institutions world-
wide and is a well-known cause of outbreaks of infection in
these settings.1 In recent years, MRSA infection has been
increasingly described in individuals with no history of re-
cent healthcare contact or other traditional risk factors for
MRSA colonization,2-4 and a number of outbreaks of
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With the exception of a recently described outbreak of MRSA
infection in children who were vaccinated by a single MRSA-
colonized healthcare worker,5 the sources for these outbreaks
have not been identified. We describe the clinical, epidemio-
logical, and microbiological features of an outbreak of
“community-onset” MRSA infection associated with percuta-
neous needle procedures (joint injection and acupuncture)
performed by a medical practitioner who was colonized with
the same MRSA clone [ST22-MRSA-IV (EMRSA-15)].
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Initial Case Identification
In May 2004, 3 patients with invasive community-onset MRSA
infection (patients 2–4; Table 1) presented to a single teaching
hospital in Perth, Western Australia, during a 16-day period.
None of the patients had risk factors for healthcare-associated
MRSA infection according to previously published criteria.6 It was
noted in the routine diagnostic laboratory that the organisms iso-
lated from the 3 cases had the typical phenotypic characteristics of
ST22-MRSA-IV (EMRSA-15); that is, they were resistant to cip-
rofloxacin and erythromycin and tested negative for urease pro-
duction. This finding was unusual, as this MRSA clone is rarely
found in the general community in our region, other than in in-
dividuals with recent healthcare facility contact.3
The 3 patients were reviewed by medical staff from the De-
partment of Microbiology and Infectious Diseases shortly after
their presentation. All 3 patients reported a history of having
undergone 1 or more percutaneous needle procedures, de-
scribed by them as either “acupuncture” or “joint injection,”
performed by a medical practitioner (Dr. A) in solo general
practice (primary care) in the Perth metropolitan area, shortly
before developing symptoms and signs of infection.
The infection cluster was reported to the Communicable
Disease Control Directorate at the Western Australian Depart-
ment of Health, who initiated a broader investigation (MRSA
infection is a notifiable disease in Western Australia).
Further Case Ascertainment and Outbreak Investigation
Infectious disease physicians and clinical microbiologists in
clinical practice in the state of Western Australia were con-
table 1. Characteristics of and Outcomes for 8 Patients Who Deve
Percutaneous Needle Procedures Performed by a Single Medical Prac
Patient
Age in years,
sex Procedure performed Site of procedur
1 72, M Joint injection Left shoulder
2 78, F Acupuncture Right shoulder
3 76, M Acupuncture Right shoulder
4 38, F Acupuncture Lower back
5 55, F Acupuncture Neck
6 65, F Joint injection Right shoulder
7 76, F Acupuncture Lower back
8 43, M Acupuncture Right hip
note. Dox, doxycycline; FA, fusidic acid; Lzd, linezolid; Rif, rifampicin; T
a Patient 7 also had possible tricuspid valve endocarditis.tacted by e-mail to determine whether they were aware of anyrecent or current cases of infection caused by ST22-MRSA-IV
(EMRSA-15) in patients with a prior history of percutaneous
needle procedures. Those who reported being aware of, or hav-
ing consulted on or managed, such a case were sent a case
report form to complete. The data collected included demo-
graphic information, names of hospitals, dates of hospital ad-
mission and discharge, the dates and nature of percutaneous
needle procedures reportedly performed before admission, site
and type of infection, antimicrobial therapy received before
and after admission, and details of surgery or percutaneous
drainage procedures performed during hospitalization.
In addition, to identify further cases, Dr. A provided access
to his patient database, and demographic details (eg, patient
name and date of birth) were cross-referenced with the MRSA
database at the Western Australian Gram-Positive Bacteria
Typing and Research Unit (GPTU). Patients who were identi-
fied in both databases had their medical records reviewed.
Surveillance and Infection Control Interventions
MRSA surveillance. Swab specimens from the anterior
nares, hands, and throat of Dr. A were obtained for MRSA
culture. In brief, swab specimens were inoculated onto
MRSA-selective agar (methicillin-aztreonam mannitol salt
[MAMSA] agar) and placed into MRSA-selective enrich-
ment broth (methicillin-aztreonam salt nutrient broth),
both of which were incubated at 35°C for 20 hours, as de-
scribed elsewhere.7 The enrichment broth was then subcul-
tured onto MAMSA agar and incubated for another 20
hours. Yellow colonies that grew on MAMSA agar that
tested positive in the tube coagulase test (ie, suspected
MRSA) were sent to the GPTU for confirmation of identi-
d Invasive Methicillin-Resistant Staphylococcus aureus Infection After
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cp, tfication and for molecular typing, as described below.
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mental MRSA contamination were taken from Dr. A’s pre-
mises. Swab specimens were taken from numerous surfaces
and objects in the treatment room; in addition, swab speci-
mens of the contents of bottles of 10% povidone-iodine (Be-
tadine) solution and 2.5% iodine tincture used for skin disin-
fection were also taken.
Audit of premises and practices. Dr. A voluntarily initiated
an infection control audit of his premises and practices; this
audit was performed by an infection control professional in
accordance with local, state, and national standards and guide-
lines (references available on request). Firstly, a comprehen-
sive review of Dr. A’s work and treatment areas was performed,
which included an inspection of hand hygiene facilities, per-
sonal protective equipment, single-use devices and medica-
tion, injectable cosmetic and therapeutic agents, linen and
laundry services, the handling and disposal of needles and
other sharp devices, the management of clinical and related
waste, the reprocessing of reusable instruments and equip-
ment, the collection and refrigeration of specimens, and the
management of environmental hygiene and spills, as well as a
review of the infection control policies and education and
training requirements. Secondly, we directly observed Dr. A
simulating the setup and sterile technique he used during deep
percutaneous needle procedures (eg, “deep” acupuncture and
joint injection), which included equipment setup, hand hy-
giene, sterile gloving, and skin disinfection techniques. After
this initial audit, a report was provided to Dr. A, and another
audit was performed to assess adherence with recommenda-
tions made after the initial audit.
Organism Identification and Epidemiologic Typing
All MRSA isolates from all microbiology laboratories in West-
ern Australia recovered from patients with no prior history of
MRSA infection or colonization within the previous year are
routinely sent to the GPTU for confirmation and epidemiolog-
ical typing. Isolates were identified as S. aureus in the referring
laboratories on the basis of positive results of standard labora-
tory tests (Gram staining, catalase test, and tube coagulase
test). These laboratories used resistance to oxacillin, methicil-
lin, or cefoxitin to determine that the isolate was probable
MRSA prior to sending the isolate to the GPTU. Comprehen-
sive typing was performed on MRSA isolates from the 8 cases
and on 2 isolates recovered from surveillance swab specimens
from Dr. A, using a combination of phenotypic and genotypic
methods, as described below.
Phenotypic typing methods. Urease production was tested
by inoculation of the MRSA isolate onto Christensen agar in
diagonally oriented test tubes, which were incubated for 24
hours at 35°C. An antibiogram was determined by testing the
isolates on Mueller-Hinton agar, using the disk diffusion
method in accordance with the methodology of the Clinical
and Laboratory Standards Institute (CLSI, formerly the Na-
tional Committee on Clinical Laboratory Standards).8 Methi-cillin resistance was confirmed by testing a 1 g oxacilline disk;
other antimicrobials tested included erythromycin, tetracy-
cline, trimethoprim, ciprofloxacin, gentamicin, rifampicin, fu-
sidic acid, and mupirocin.8 Standard French susceptibility test-
ing interpretative criteria were used for fusidic acid results,9
and previously published interpretative criteria were used for
mupirocin results.10 CLSI criteria were used to interpret results
for the other agents.11 A resistogram was determined by the
disk diffusion method for each isolate’s resistance to cadmium
acetate (concentration, 10 mmol/L), sodium arsenate (0.2
mol/L), ethidium bromide (15 mmol/L), propanimide is-
ethionate (2% [wt/vol]), mercuric chloride (0.4 mol/L), and
phenylmercuric acetate (5 mmol/L), as described else-
where.12,13 Bacteriophage typing was also performed using the
International Basic, International MRSA, and Australian
MRSA phage sets, as described elsewhere.14
Genotypic typing methods. Confirmatory molecular MRSA
identification tests performed included multiplex real-time
polymerase chain reaction to detect the mecA and nuc genes.15
Coagulase gene restriction fragment–length polymorphism
(coaRFLP) analysis was performed according to a method de-
scribed elsewhere.16 Contour-clamped homogenous electric
field (CHEF) electrophoresis analysis of chromosomal DNA
following digestion with both Sma1 and Apa1 restriction en-
zymes was performed as described elsewhere,17 using the
CHEF DR III System (Bio-Rad Laboratories). CHEF patterns
were visualized and grouped according to the criteria of
Tenover et al.18; isolates with 80% or greater similarity (by Dice
coefficient) were considered to belong to the same strain. A
band-based dendrogram was produced by using Dice coeffi-
cients and an unweighted pair group method using arithmetic
averages (UPGMA). An optimization tolerance of 0.50% and a
band position tolerance of 1.00% were used.
An independent laboratory performed automated ribo-
somal DNA analysis (ribotyping) using an automated system
(RiboPrinter; Dupont Qualicon) on the isolates, together with
a collection of other ST22-MRSA-IV (EMRSA-15) isolates ob-
tained from patients who were not epidemiologically linked to
the infection cluster. A UPGMA dendrogram of the ribotyping
patterns was generated using BioNumerics software, version
3.5 (Applied Maths); bands were based on densitometric
curves using the cosine coefficient. Finally, multilocus se-
quence typing (MLST) and staphylococcal cassette chromo-
some mec (SCCmec) allotyping were performed, according to
previously described methods,19 on selected isolates to confirm
previously described associations between coa RFLP, CHEF
patterns, and MLST and SCCmec type in MRSA clones in our
region.20 Sequence types were allocated after a BURST (Based
Upon Related Sequence Types) analysis.21
results
Description of the Outbreak
Invasive community-onset MRSA infection was identified in 8
patients who had undergone 1 or more percutaneous needle
862 infection control and hospital epidemiology september 2008, vol. 29, no. 9procedures performed by Dr. A. Patients described the nature
of the procedure(s) performed as either “deep acupuncture” or
“joint injection.” Seven patients (patients 2– 8) presented to 4
different hospitals in the Perth metropolitan area in May 2004.
The other patient (patient 1) presented in February 2003, ap-
proximately 15 months before the cluster of 7 cases occurred
(Figure 1).
Dr. A’s medical records were examined to determine the
exact dates of the procedures performed. Dr. A was unable to
recall the specific details of many of the procedures, including
what medications were injected; however, he reported always
using single-use needles and medication vials.
The demographic and clinical characteristics of the patients,
the clinical presentation of the infections, and the definitive
antimicrobial therapy, are presented in Table 1. All patients
presented with deep-seated MRSA infection in the same ana-
tomical area where Dr. A had performed a percutaneous nee-
dle procedure. One patient (patient 7) had at least 1 procedure
performed at home. Three patients had bacteremia at the time
of presentation, 1 of whom had possible tricuspid valve endo-
carditis, according to modified Duke criteria.22 All patients re-
quired hospitalization to undergo surgery and/or percutane-
ous drainage and to receive intravenous antimicrobial therapy.
The median duration of hospitalization was 22 days (range,
7– 62 days). All patients required prolonged antimicrobial
therapy (median duration, 72 days; range, 21–127 days). None
of the patients died.
Epidemiological Typing of MRSA Isolates
All of the MRSA isolates from the 8 case patients demonstrated
an identical phenotype, consistent with the ST22-MRSA-IV
(EMRSA-15 MRSA) clone (ie, negative urease test results, re-
sistance to ciprofloxacin and erythromycin, resistance to cad-
figure 1. Timeline showing the dates of acupuncture or joint in-
jection (solid triangles) and the dates of admission to hospital for treat-
ment of invasive methicillin-resistant Staphylococcus aureus infection
(solid bars) for patients involved in the outbreak.mium acetate and sodium arsenate, and not typeable withphage sets from International Basic, International MRSA, and
Australian MRSA). In addition, the isolates were genotypically
indistinguishable by the 3 different methods used (ie, coaRFLP
analysis, CHEF electrophoresis, and ribotyping). Two isolates
(1 isolate from patient 1 and 1 isolate from Dr. A’s 2003 nasal
specimen) were confirmed to be ST22-MRSA-IV by use of
MLST and SCCmec allotyping.
The nasal swab specimens obtained from Dr. A after recog-
nition of the outbreak in May 2004 yielded a strain of MRSA on
culture that was phenotypically and genotypically indistin-
guishable from the strains isolated from the 8 patients (Figures
2 and 3). On review of the GPTU MRSA database, it was de-
termined that swab specimens obtained from Dr. A in March
2003 (after the initial case of invasive MRSA infection in pa-
tient 1, in February 2003) had yielded MRSA on culture. This
strain was also phenotypically and genotypically indistinguish-
able from the strain recovered from the 8 patients during
2003–2004 and from the strain isolated from swab specimens
of Dr. A’s anterior nares obtained in May 2004.
CHEF and ribosomal DNA analysis results are presented in
detail in Figures 2 and 3. Ribotyping demonstrated that MRSA
isolates from the 8 patients and from Dr. A clustered in 1 ribo-
group (designated 124-S-6), which was distinguishable (by a
single band difference) from other ST22-MRSA-IV (EMRSA-
15) isolates obtained from case patients with invasive MRSA
infection not epidemiologically related to the outbreak (desig-
nated 102-S-3).
Infection Control Interventions
The audit of Dr. A’s premises and practices identified multiple
areas of nonadherence to standards outlined in local infection
control guidelines and recommendations. The procedure room
was small, cluttered with nonessential items, had excessive dust on
several surfaces, and contained numerous products that were be-
yond their expiration dates (eg, alcohol chlorhexidine handrub,
sterile gloves, single-use acupuncture needles, scalp vein needles,
scalpels, dressings, medical equipment and instrument cleaner,
purified water, and single-use medication vials of atropine sulfate
figure 2. Pulsed-field gel electrophoresis band patterns for chro-
mosomal DNA (after SmaI enzyme restriction) of methicillin-
resistant Staphylococcus aureus isolates obtained from the 8 patients
involved in the outbreak and from the medical practitioner (Dr. A) in
March 2003 and May 2004. The band pattern for S. aureus strain
NCTC 8325 was used as a size marker.
mrsa outbreak associated with percutaneous needle procedures 863at a concentration of 600 g/mL, bupivicaine at a concentration
of 0.5%, and adrenaline at a concentration of 1:1,000). The ob-
served simulation of sterile technique during a percutaneous nee-
dle procedure demonstrated a number of potentially significant
deficiencies (eg, turning the tap off with clean hands; touching a
sterile, gloved hand with an ungloved hand; and use of nonsterile
figure 3. Ribotyping results and a dendrogram for methicillin
patients involved in the outbreak and the medical practitioner (Dr. A
selection of ST-22-MRSA-IV (EMRSA-15) isolates obtained from t
Typing and Research Unit.tissue paper to remove excess povidone-iodine solution used forskin disinfection). None of the environmental swab specimens
yielded MRSA.
At a subsequent reaudit (3 weeks after the initial audit), sig-
nificant improvement was demonstrated in infection control
standards and practices and in sterile technique during a sim-
ulated percutaneous needle procedure. No further audits were
stant Staphylococcus aureus (MRSA) isolates recovered from the 8
March 2003 and May 2004. The other isolates tested are a random
ulture collection of the Western Australian Gram-Positive Bacteria-resi
) in
he cperformed.
864 infection control and hospital epidemiology september 2008, vol. 29, no. 9After receipt of the MRSA-positive culture results in May
2004, Dr. A commenced on a 10-day course of decolonization
therapy, which consisted of 2% mupirocin nasal ointment ap-
plied 3 times daily to each nostril, 3% hexachlorophene body
wash applied daily while bathing, and 20% cetrimide shampoo
applied every third day, in accordance with local MRSA decol-
onization protocols. Surveillance swab specimens that were
collected 5 days after decolonization therapy was completed
were found to be negative for MRSA on culture; further
follow-up swab specimens for culture surveillance of MRSA
were not obtained.
After recognition of the outbreak and the institution of the
above-mentioned interventions, ongoing passive surveillance
has not detected any further cases of MRSA infection associ-
ated with percutaneous needle procedures performed by Dr. A.
discussion
To our knowledge, this is the first description of an outbreak of
invasive community-onset MRSA infection associated with ei-
ther acupuncture or joint injection. Recently, an outbreak of
MRSA infection associated with routine childhood vaccina-
tion was reported in Vietnam,5 and it shares many of the fea-
tures described in our report. In the outbreak in Vietnam re-
ported by Tang et al.,5 the resultant MRSA infections were
moderate to severe (including 1 that resulted in death), requir-
ing hospitalization for surgical intervention and/or adminis-
tration of systemic antimicrobial therapy. Several patients were
admitted to the same hospital in a short period of time, thereby
alerting clinicians to the outbreak and allowing further case
identification and interventions to prevent further cases, and a
healthcare worker performing needle-based percutaneous
procedures was found to be colonized with the same MRSA
clone that caused the infection in the patients.
The outbreak that we investigated was likely caused by a
breakdown in hand hygiene and/or sterile technique during
percutaneous needle procedures, resulting in transmission of
MRSA from Dr. A to the patients. This is supported by the
findings that (1) Dr. A was colonized with the same MRSA
clone that caused the infections at 2 time points, separated by
15 months, and (2) the infection control audit demonstrated
multiple breaches in infection control standards and practices
that could have provided the opportunity for MRSA transmis-
sion. Although it is theoretically possible that an unidentified
environmental source was responsible for the outbreak (eg,
contaminated medication or skin preparation solution, or re-
used needles that were not reported), we consider this unlikely,
particularly because 1 patient was treated exclusively in their
home.
There are numerous reports in the medical literature of sin-
gle cases and outbreaks of serious infection associated with
acupuncture. Large prospective studies of acupuncture have
reported low rates of serious adverse events, including infec-
tion23,24; however, these studies are significantly limited by the
fact that practitioners were asked to self-report adverse events.When serious and/or invasive bacterial infection has been as-
sociated with acupuncture, S. aureus has frequently been the
cause. A recent literature review of S. aureus infections associ-
ated with acupuncture described 9 cases, the majority of which
resulted in bone and/or joint infections and/or bacteremia.25
Minimal published data exist on the incidence of serious
infection after joint injection. A recent report described an out-
break of S. aureus joint and soft-tissue infections after thera-
peutic injections performed by a single physician; in that out-
break, a multiple-dose vial of lidocaine was implicated as (but
not proven to be) the likely source for these infections.26 Like
the outbreak of invasive MRSA associated with percutaneous
needle procedures that we investigated, the outbreak described
in Kirschke et al.26 was terminated after identification of the
potential source.
This study has a number of limitations. Firstly, we did not
perform a case-control study to more precisely determine risk
factors for MRSA infection after acupuncture or joint injection
performed by Dr. A. Secondly, it is possible that unidentified
cases of less severe MRSA infection occurred but were not rec-
ognized, because appropriate specimens were not collected for
culture and susceptibility testing. Thirdly, we were unable to
perform long-term surveillance of MRSA colonization on Dr.
A, so we were unable to determine whether Dr. A’s decoloni-
zation therapy was successful.
Outbreaks of MRSA in either healthcare or community set-
tings may be difficult to detect, but it is important to do so
because they can result in considerable morbidity and even
mortality. In Western Australia, the long-term MRSA surveil-
lance program based in the GPTU has allowed for a compre-
hensive characterization of the epidemiology of MRSA in our
region. In addition, effective and timely collaboration between
the GPTU, referring laboratories, infection control practitio-
ners, and the Communicable Diseases Control Directorate at
the Western Australian Department of Health has facilitated
the control of endemic MRSA in hospitals and other healthcare
facilities in our region for more than 20 years.20 Together with
the recent report of control of an outbreak of the New York/
Japan MRSA clone in our region,27 this report demonstrates
that identification and control of MRSA outbreaks outside of
large healthcare facilities is also possible.
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